{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:05:14Z","timestamp":1781082314446,"version":"3.54.1"},"reference-count":239,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":107,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Brain metastases (BMs) increasingly represent a significant cause of morbidity and mortality in cancer patients. The efficacy of systemic therapies for BMs, in contrast to extracranial metastases (EMs), remains limited secondary to a host of challenges. These include insufficient drug delivery due to the blood\u2013brain barrier and blood-tumor barrier, the unique immunological milieu in the tumor microenvironment and cerebrospinal fluid, the diversity of immunogenomic landscapes in BMs across genetically distinct malignancies, the branching evolution of BM from EMs, and the challenges in longitudinally obtaining information regarding clinically actionable genetic alterations in BMs for precision oncology. These complex, long-standing challenges require treatment strategies that address multiple problems concurrently, as represented by the potential of focused ultrasound (FUS) for enhancing effectiveness of several existing BM-specific management strategies. Beyond historically investigated applications of FUS for BMs, including thermoablation and histotripsy, new frontiers include enhanced drug delivery of systemic therapies, plasma sono-liquid biopsy of BM-derived factors, radiosensitization, and immunomodulation. These applications, as discussed here, enable multiple combinatorial opportunities of FUS with targeted- and\/or immunotherapies for BMs. With multiple ultrasound delivery platforms (including MR-guided, neuro-navigation-guided, and implantable devices) being investigated in neuro-oncology trials worldwide, this review provides strategies for designing and optimizing future research efforts.<\/jats:p>","DOI":"10.1093\/noajnl\/vdaf131","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:43:50Z","timestamp":1753357430000},"page":"iv40-iv59","source":"Crossref","is-referenced-by-count":0,"title":["Focused ultrasound for brain metastases"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6570-4541","authenticated-orcid":false,"given":"Ahmad","family":"Ozair","sequence":"first","affiliation":[{"name":"Brain Tumor Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center , Baltimore, MD ,","place":["USA"]},{"name":"Department of Neurosurgery, University of Maryland School of Medicine , Baltimore, MD ,","place":["USA"]},{"name":"Department of Neurology and Neurosurgery, McGill University , Montreal, QC ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7378-6399","authenticated-orcid":false,"given":"Bilal","family":"Moiz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Maryland School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0230-7925","authenticated-orcid":false,"given":"Pavlos","family":"Anastasiadis","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine , Baltimore, MD ,","place":["USA"]},{"name":"Brain Tumor Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center , Baltimore, MD ,","place":["USA"]},{"name":"Department of Neurosurgery, University of Maryland School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6741-5970","authenticated-orcid":false,"given":"Dheeraj","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine , Baltimore, MD ,","place":["USA"]},{"name":"Department of Neurosurgery, University of Maryland School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9429-7074","authenticated-orcid":false,"given":"Bibhas","family":"Amatya","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Maryland School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7944-5181","authenticated-orcid":false,"given":"Michael W","family":"McDermott","sequence":"additional","affiliation":[{"name":"Herbert Wertheim College of Medicine, Florida International University , Miami, FL ,","place":["USA"]},{"name":"Miami Neuroscience Institute, Baptist Health South Florida , Miami, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9663-0768","authenticated-orcid":false,"given":"Graeme F","family":"Woodworth","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine , Baltimore, MD ,","place":["USA"]},{"name":"Brain Tumor Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center , Baltimore, MD ,","place":["USA"]},{"name":"Department of Neurosurgery, University of Maryland School of Medicine , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-9511","authenticated-orcid":false,"given":"Manmeet S","family":"Ahluwalia","sequence":"additional","affiliation":[{"name":"Miami Cancer Institute, Baptist Health South Florida , Miami, FL ,","place":["USA"]},{"name":"Herbert Wertheim College of Medicine, Florida International University , Miami, FL ,","place":["USA"]},{"name":"Miami Neuroscience Institute, Baptist Health South Florida , Miami, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"9","key":"2026061004511805500_CIT0001","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","article-title":"Epidemiology of brain metastases and leptomeningeal disease","volume":"23","author":"Lamba","year":"2021","journal-title":"Neuro-Oncology."},{"issue":"11","key":"2026061004511805500_CIT0002","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol"},{"issue":"1","key":"2026061004511805500_CIT0003","first-page":"vdaa178","article-title":"Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study","volume":"3","author":"Habbous","year":"2021","journal-title":"Neurooncol. Adv.."},{"issue":"11","key":"2026061004511805500_CIT0004","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.bjc.6605373","article-title":"Brain metastases admissions in Sweden between 1987 and 2006","volume":"101","author":"Smedby","year":"2009","journal-title":"Br J Cancer."},{"issue":"14","key":"2026061004511805500_CIT0005","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"2026061004511805500_CIT0006","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nec.2020.06.001","article-title":"Epidemiology of Brain Metastases","volume":"31","author":"Sacks","year":"2020","journal-title":"Neurosurg Clin N Am."},{"issue":"10","key":"2026061004511805500_CIT0007","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/neuonc\/noac118","article-title":"Brain metastases: a society for Neuro-Oncology (SNO) consensus review on current management and future directions","volume":"24","author":"Aizer","year":"2022","journal-title":"Neuro Oncol"},{"issue":"2","key":"2026061004511805500_CIT0008","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/neuonc\/now241","article-title":"Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of neuro-oncology (EANO)","volume":"19","author":"Soffietti","year":"2017","journal-title":"Neuro-Oncology."},{"issue":"6","key":"2026061004511805500_CIT0009","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-0043-1776782","article-title":"Management of Brain Metastases: a review of novel therapies","volume":"43","author":"Bellur","year":"2023","journal-title":"Semin Neurol."},{"issue":"10","key":"2026061004511805500_CIT0010","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/neuonc\/noaa142","article-title":"Baseline requirements for novel agents being considered for phase II\/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium\u2019s first workshop on CNS drug delivery","volume":"22","author":"Grossman","year":"2020","journal-title":"Neuro Oncol"},{"issue":"8","key":"2026061004511805500_CIT0011","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1016\/S1470-2045(23)00297-8","article-title":"National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities","volume":"24","author":"Kim","year":"2023","journal-title":"Lancet Oncol."},{"issue":"4","key":"2026061004511805500_CIT0012","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat Rev Mater."},{"issue":"7","key":"2026061004511805500_CIT0013","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell."},{"issue":"2","key":"2026061004511805500_CIT0014","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jtho.2023.09.276","article-title":"Genetic Intratumor heterogeneity remodels the immune microenvironment and induces immune evasion in brain metastasis of lung cancer","volume":"19","author":"Wang","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"1","key":"2026061004511805500_CIT0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ccell.2019.12.004","article-title":"Cancer genome evolutionary trajectories in metastasis","volume":"37","author":"Birkbak","year":"2020","journal-title":"Cancer Cell"},{"issue":"11","key":"2026061004511805500_CIT0016","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov"},{"issue":"8005","key":"2026061004511805500_CIT0017","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41586-024-07177-7","article-title":"Evolutionary trajectories of small cell lung cancer under therapy","volume":"627","author":"George","year":"2024","journal-title":"Nature."},{"issue":"7964","key":"2026061004511805500_CIT0018","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41586-023-06054-z","article-title":"Pan-cancer whole-genome comparison of primary and metastatic solid tumours","volume":"618","author":"Martinez-Jimenez","year":"2023","journal-title":"Nature."},{"issue":"1","key":"2026061004511805500_CIT0019","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1038\/s41467-023-40793-x","article-title":"Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis","volume":"14","author":"Skakodub","year":"2023","journal-title":"Nat Commun."},{"issue":"5","key":"2026061004511805500_CIT0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol."},{"issue":"3","key":"2026061004511805500_CIT0021","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/neuonc\/noae267","article-title":"NCCN CNS tumor guidelines update for 2024","volume":"27","author":"Nabors","year":"2025","journal-title":"Neuro-Oncology."},{"issue":"3","key":"2026061004511805500_CIT0022","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2217\/cns-2017-0014","article-title":"CNS anticancer drug discovery and development: 2016 conference insights","volume":"6","author":"Levin","year":"2017","journal-title":"CNS Oncol"},{"issue":"5","key":"2026061004511805500_CIT0023","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/neuonc\/noz012","article-title":"Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications","volume":"21","author":"Boire","year":"2019","journal-title":"Neuro-Oncology."},{"issue":"1","key":"2026061004511805500_CIT0024","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S1470-2045(17)30693-9","article-title":"Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group","volume":"19","author":"Camidge","year":"2018","journal-title":"Lancet Oncol."},{"issue":"1","key":"2026061004511805500_CIT0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41523-023-00550-1","article-title":"Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer","volume":"9","author":"Morganti","year":"2023","journal-title":"npj Breast Cancer."},{"issue":"2","key":"2026061004511805500_CIT0026","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/annonc\/mdy544","article-title":"Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases","volume":"30","author":"Seoane","year":"2019","journal-title":"Ann Oncol."},{"key":"2026061004511805500_CIT0027","article-title":"Applications of transcranial focused ultrasound for primary brain tumors","author":"Ozair","year":"2025","journal-title":"Neurooncol. Adv.."},{"key":"2026061004511805500_CIT0028","article-title":"Development of skull-implanted ultrasound for blood-brain barrier opening and drug delivery in Neuro-Oncology","author":"Sonabend","year":"2025","journal-title":"Neurooncol. Adv."},{"key":"2026061004511805500_CIT0029","article-title":"Focused ultrasound in pediatric Neuro-Oncology","author":"Rutka","year":"2025","journal-title":"Neurooncol. Adv."},{"issue":"3","key":"2026061004511805500_CIT0030","first-page":"637","article-title":"Histology of cerebral lesions produced by focused ultrasound","volume":"20","author":"Lynn","year":"1944","journal-title":"Am J Pathol."},{"issue":"4","key":"2026061004511805500_CIT0031","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.mric.2024.04.002","article-title":"Transcranial focused ultrasound: a history of our future","volume":"32","author":"Ahmed","year":"2024","journal-title":"Magn Reson Imaging Clin N Am."},{"issue":"6","key":"2026061004511805500_CIT0032","first-page":"469","article-title":"Ultrasound augmentation of central nervous system tumor therapy","volume":"78","author":"Heimburger","year":"1985","journal-title":"Ind. Med."},{"issue":"3","key":"2026061004511805500_CIT0033","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1109\/IRET-ME.1960.5008041","article-title":"Fundamental neurological research and human neurosurgery using intense ultrasound","volume":"ME-7","author":"Fry","year":"1960","journal-title":"IRE Trans Med Electron."},{"issue":"3168","key":"2026061004511805500_CIT0034","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.122.3168.517","article-title":"Ultrasonic lesions in the mammalian central nervous system","volume":"122","author":"Fry","year":"1955","journal-title":"Science."},{"issue":"4","key":"2026061004511805500_CIT0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1121\/1.1906912","article-title":"Mechanism of acoustic absorption in tissue","volume":"24","author":"Fry","year":"1952","journal-title":"J Acoust Soc Am."},{"issue":"6","key":"2026061004511805500_CIT0036","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1121\/1.1906707","article-title":"Physical factors involved in ultrasonically induced changes in living systems: I. identification of non-temperature effects","volume":"22","author":"Fry","year":"1950","journal-title":"J Acoust Soc Am."},{"issue":"3","key":"2026061004511805500_CIT0037","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1121\/1.1906774","article-title":"Physical factors involved in ultrasonically induced changes in living systems: II. Amplitude duration relations and the effect of hydrostatic pressure for nerve tissue","volume":"23","author":"Fry","year":"1951","journal-title":"J Acoust Soc Am."},{"issue":"1","key":"2026061004511805500_CIT0038","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3171\/jns.1959.16.1.0032","article-title":"Early experiences with ultrasonic irradiation of the pallidofugal and nigral complexes in hyperkinetic and hypertonic disorders","volume":"16","author":"Meyers","year":"1959","journal-title":"J Neurosurg."},{"issue":"3168","key":"2026061004511805500_CIT0039","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.122.3168.517","article-title":"Ultrasonic lesions in the mammalian central nervous system","volume":"122","author":"Fry","year":"1955","journal-title":"Science."},{"issue":"5","key":"2026061004511805500_CIT0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3171\/jns.1954.11.5.0471","article-title":"Production of focal destructive lesions in the central nervous system with ultrasound","volume":"11","author":"Fry","year":"1954","journal-title":"J Neurosurg."},{"issue":"4","key":"2026061004511805500_CIT0041","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00005072-195910000-00001","article-title":"Pathological effects of ultrasound on the human brain: a study of 25 cases in which ultrasonic irradiation was used as a lobotomy procedure","volume":"18","author":"Nelson","year":"1959","journal-title":"J Neuropathol Exp Neurol."},{"issue":"4","key":"2026061004511805500_CIT0042","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archneurpsyc.1954.02330040001001","article-title":"Prefrontal ultrasonic irradiation-a substitute for lobotomy","volume":"72","author":"Lindstrom","year":"1954","journal-title":"AMA Arch Neurol Psychiatry"},{"issue":"4","key":"2026061004511805500_CIT0043","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0360-3016(92)90711-P","article-title":"Treatment of malignant gliomas with interstitial irradiation and hyperthermia","volume":"24","author":"Stea","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"2026061004511805500_CIT0044","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00177540","article-title":"Treatment of malignant brain tumors with focused ultrasound hyperthermia and radiation: results of a phase I trial","volume":"10","author":"Guthkelch","year":"1991","journal-title":"J Neurooncol."},{"issue":"2","key":"2026061004511805500_CIT0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0022-3468(92)90321-W","article-title":"Effects of high-intensity focused ultrasound in the treatment of experimental neuroblastoma","volume":"27","author":"Yang","year":"1992","journal-title":"J Pediatr Surg."},{"issue":"2","key":"2026061004511805500_CIT0046","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-5629(97)00269-X","article-title":"Demonstration of potential noninvasive ultrasound brain therapy through an intact skull","volume":"24","author":"Hynynen","year":"1998","journal-title":"Ultrasound Med Biol."},{"issue":"1","key":"2026061004511805500_CIT0047","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroimage.2004.06.046","article-title":"Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications","volume":"24","author":"Hynynen","year":"2005","journal-title":"Neuroimage."},{"issue":"5","key":"2026061004511805500_CIT0048","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mrm.20060","article-title":"MRI investigation of the threshold for thermally induced blood-brain barrier disruption and brain tissue damage in the rabbit brain","volume":"51","author":"McDannold","year":"2004","journal-title":"Magn Reson Med."},{"issue":"3","key":"2026061004511805500_CIT0049","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.2202001804","article-title":"Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits","volume":"220","author":"Hynynen","year":"2001","journal-title":"Radiology."},{"issue":"3","key":"2026061004511805500_CIT0050","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00004424-199903000-00006","article-title":"Real-time control of focused ultrasound heating based on rapid MR thermometry","volume":"34","author":"Vimeux","year":"1999","journal-title":"Invest Radiol."},{"issue":"4","key":"2026061004511805500_CIT0051","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ijc.22732","article-title":"Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound","volume":"121","author":"Treat","year":"2007","journal-title":"Int J Cancer."},{"key":"2026061004511805500_CIT0052","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.10.011","article-title":"Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption","volume":"250","author":"Park","year":"2017","journal-title":"J Contr Release."},{"key":"2026061004511805500_CIT0053","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2015.02.033","article-title":"Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study","volume":"204","author":"Aryal","year":"2015","journal-title":"J Contr Release."},{"issue":"6","key":"2026061004511805500_CIT0054","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1088\/0031-9155\/60\/6\/2511","article-title":"Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model","volume":"60","author":"Aryal","year":"2015","journal-title":"Phys Med Biol."},{"key":"2026061004511805500_CIT0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2014.01.008","article-title":"Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system","volume":"72","author":"Aryal","year":"2014","journal-title":"Adv Drug Deliv Rev."},{"issue":"1-2","key":"2026061004511805500_CIT0056","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2013.04.007","article-title":"Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model","volume":"169","author":"Aryal","year":"2013","journal-title":"J. Contr. Release"},{"issue":"12","key":"2026061004511805500_CIT0057","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.7150\/thno.5576","article-title":"Optimization of the ultrasound-induced blood-brain barrier opening","volume":"2","author":"Konofagou","year":"2012","journal-title":"Theranostics."},{"issue":"14","key":"2026061004511805500_CIT0058","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-12-0128","article-title":"Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques","volume":"72","author":"McDannold","year":"2012","journal-title":"Cancer Res."},{"issue":"40","key":"2026061004511805500_CIT0059","doi-asserted-by":"crossref","first-page":"16539","DOI":"10.1073\/pnas.1105116108","article-title":"Noninvasive and localized neuronal delivery using short ultrasonic pulses and microbubbles","volume":"108","author":"Choi","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"2026061004511805500_CIT0060","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.ultrasmedbio.2011.08.004","article-title":"Cavitation-enhanced extravasation for drug delivery","volume":"37","author":"Arvanitis","year":"2011","journal-title":"Ultrasound Med Biol."},{"issue":"9","key":"2026061004511805500_CIT0061","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ultrasmedbio.2010.06.005","article-title":"Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study","volume":"36","author":"Baseri","year":"2010","journal-title":"Ultrasound Med Biol."},{"issue":"2","key":"2026061004511805500_CIT0062","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1148\/radiol.10090699","article-title":"Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment","volume":"255","author":"Liu","year":"2010","journal-title":"Radiology."},{"issue":"11","key":"2026061004511805500_CIT0063","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1039\/b823051j","article-title":"Drug loaded microbubble design for ultrasound triggered delivery","volume":"5","author":"Lentacker","year":"2009","journal-title":"Soft Mat."},{"key":"2026061004511805500_CIT0064","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.50803532025","article-title":"Acoustic emissions dose and spatial control of blood-brain barrier opening with focused ultrasound","author":"Woodworth","journal-title":"Device. 2025 (In-Press)"},{"issue":"2","key":"2026061004511805500_CIT0065","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/2017.11.FOCUS17631","article-title":"A minimally invasive catheter-based ultrasound technology for therapeutic interventions in brain: initial preclinical studies","volume":"44","author":"Ghoshal","year":"2018","journal-title":"Neurosurg Focus."},{"issue":"Supplement_8","key":"2026061004511805500_CIT0066","doi-asserted-by":"crossref","first-page":"viii99","DOI":"10.1093\/neuonc\/noae165.0385","article-title":"CTNI-18. Results from a phase 1 study of sonodynamic therapy with whole hemispheric low intensity non-ablative ultrasound in patients with recurrent high grade glioma","volume":"26","author":"Schulder","year":"2024","journal-title":"Neuro-Oncology."},{"issue":"13","key":"2026061004511805500_CIT0067","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-18-3643","article-title":"Safety and feasibility of repeated and transient blood-brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma","volume":"25","author":"Idbaih","year":"2019","journal-title":"Clin Cancer Res."},{"issue":"343","key":"2026061004511805500_CIT0068","doi-asserted-by":"crossref","first-page":"343re342","DOI":"10.1126\/scitranslmed.aaf6086","article-title":"Clinical trial of blood-brain barrier disruption by pulsed ultrasound","volume":"8","author":"Carpentier","year":"2016","journal-title":"Sci Transl Med."},{"issue":"1","key":"2026061004511805500_CIT0069","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","article-title":"Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial","volume":"15","author":"Carpentier","year":"2024","journal-title":"Nat Commun."},{"issue":"1","key":"2026061004511805500_CIT0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41698-023-00448-y","article-title":"First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound","volume":"7","author":"Yuan","year":"2023","journal-title":"NPJ Precis Oncol."},{"issue":"1","key":"2026061004511805500_CIT0071","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ultrasmedbio.2019.09.010","article-title":"A clinical system for non-invasive blood-brain barrier opening using a neuronavigation-guided single-element focused ultrasound transducer","volume":"46","author":"Pouliopoulos","year":"2020","journal-title":"Ultrasound Med Biol."},{"issue":"2","key":"2026061004511805500_CIT0072","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1227\/01.NEU.0000360379.95800.2F","article-title":"Transcranial magnetic resonance imaging- guided focused ultrasound surgery of brain tumors: initial findings in 3 patients","volume":"66","author":"McDannold","year":"2010","journal-title":"Neurosurgery."},{"issue":"615","key":"2026061004511805500_CIT0073","doi-asserted-by":"crossref","first-page":"eabj4011","DOI":"10.1126\/scitranslmed.abj4011","article-title":"MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases","volume":"13","author":"Meng","year":"2021","journal-title":"Sci Transl Med."},{"issue":"1","key":"2026061004511805500_CIT0074","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41598-018-36340-0","article-title":"Blood-brain barrier opening in primary brain tumors with non-invasive mr-guided focused ultrasound: a clinical safety and feasibility study","volume":"9","author":"Mainprize","year":"2019","journal-title":"Sci Rep."},{"issue":"6","key":"2026061004511805500_CIT0075","doi-asserted-by":"crossref","first-page":"eabd0772","DOI":"10.1126\/sciadv.abd0772","article-title":"Neuronavigation-guided focused ultrasound for transcranial blood-brain barrier opening and immunostimulation in brain tumors","volume":"7","author":"Chen","year":"2021","journal-title":"Sci Adv."},{"key":"2026061004511805500_CIT0076","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jum.16600","article-title":"A wearable, steerable, transcranial low-intensity focused ultrasound system","volume":"44","author":"Bawiec","year":"2024","journal-title":"J Ultrasound Med."},{"issue":"6","key":"2026061004511805500_CIT0077","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/02656736.2013.820357","article-title":"Transcranial high intensity focused ultrasound therapy guided by 7 TESLA MRI in a rat brain tumour model: a feasibility study","volume":"29","author":"Dervishi","year":"2013","journal-title":"Int J Hyperthermia."},{"issue":"2","key":"2026061004511805500_CIT0078","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/02656736.2011.648137","article-title":"Tumour hyperthermia and ablation in rats using a clinical MR-HIFU system equipped with a dedicated small animal set-up","volume":"28","author":"Hijnen","year":"2012","journal-title":"Int J Hyperthermia."},{"issue":"4","key":"2026061004511805500_CIT0079","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1227\/01.NEU.0000245606.99946.C6","article-title":"Magnetic resonance imaging-guided focused ultrasound for thermal ablation in the brain: a feasibility study in a swine model","volume":"60","author":"Cohen","year":"2007","journal-title":"Neurosurgery."},{"issue":"1","key":"2026061004511805500_CIT0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2050-5736-2-17","article-title":"First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound","volume":"2","author":"Coluccia","year":"2014","journal-title":"J Ther Ultrasound."},{"issue":"1","key":"2026061004511805500_CIT0081","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41467-021-21022-9","article-title":"Blood-brain barrier opening with focused ultrasound in Parkinson\u2019s disease dementia","volume":"12","author":"Gasca-Salas","year":"2021","journal-title":"Nat Commun."},{"issue":"10","key":"2026061004511805500_CIT0082","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/mds.29134","article-title":"Striatal blood-brain barrier opening in Parkinson\u2019s disease dementia: a pilot exploratory study","volume":"37","author":"Pineda-Pardo","year":"2022","journal-title":"Mov Disord."},{"issue":"8","key":"2026061004511805500_CIT0083","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa2202721","article-title":"Trial of globus pallidus focused ultrasound ablation in Parkinson\u2019s disease","volume":"388","author":"Krishna","year":"2023","journal-title":"N Engl J Med."},{"issue":"8","key":"2026061004511805500_CIT0084","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1056\/NEJMoa1600159","article-title":"A randomized trial of focused ultrasound thalamotomy for essential tremor","volume":"375","author":"Elias","year":"2016","journal-title":"N Engl J Med."},{"issue":"4","key":"2026061004511805500_CIT0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA."},{"issue":"4","key":"2026061004511805500_CIT0086","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ijrobp.2014.10.024","article-title":"Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis","volume":"91","author":"Sahgal","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"2026061004511805500_CIT0087","doi-asserted-by":"crossref","first-page":"E180","DOI":"10.1093\/neuros\/nyy548","article-title":"Congress of neurological surgeons systematic review and evidence-based guidelines on treatment options for adults with multiple metastatic brain tumors","volume":"84","author":"Ammirati","year":"2019","journal-title":"Neurosurgery."},{"issue":"33","key":"2026061004511805500_CIT0088","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1200\/JCO.19.01414","article-title":"Adjuvant whole-brain radiation therapy compared with observation after local treatment of melanoma brain metastases: a multicenter, randomized phase III trial","volume":"37","author":"Hong","year":"2019","journal-title":"J Clin Oncol."},{"issue":"5","key":"2026061004511805500_CIT0089","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1227\/01.NEU.0000254439.02736.D8","article-title":"Magnetic resonance imaging-guided, high-intensity focused ultrasound for brain tumor therapy","volume":"59","author":"Ram","year":"2006","journal-title":"Neurosurgery."},{"issue":"1","key":"2026061004511805500_CIT0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41582-020-00418-z","article-title":"Applications of focused ultrasound in the brain: from thermoablation to drug delivery","volume":"17","author":"Meng","year":"2021","journal-title":"Nat Rev Neurol."},{"issue":"5","key":"2026061004511805500_CIT0091","first-page":"449","article-title":"Clinical neurological HIFU applications: the Zurich experience","volume":"3","author":"Martin","year":"2014","journal-title":"Transl Cancer Res."},{"issue":"1","key":"2026061004511805500_CIT0092","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat Rev Cancer."},{"issue":"2","key":"2026061004511805500_CIT0093","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.lungcan.2015.02.006","article-title":"A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients","volume":"88","author":"Won","year":"2015","journal-title":"Lung Cancer."},{"issue":"2","key":"2026061004511805500_CIT0094","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10549-022-06799-7","article-title":"Brain metastasis as the first and only metastatic relapse site portends worse survival in patients with advanced HER2 + breast cancer","volume":"197","author":"Noteware","year":"2023","journal-title":"Breast Cancer Res Treat."},{"issue":"12","key":"2026061004511805500_CIT0095","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/neuonc\/noad115","article-title":"A novel risk signature for predicting brain metastasis in patients with lung adenocarcinoma","volume":"25","author":"Zhao","year":"2023","journal-title":"Neuro Oncol"},{"issue":"1","key":"2026061004511805500_CIT0096","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11060-019-03149-4","article-title":"Natural history, clinical course and predictors of interval time from initial diagnosis to development of subsequent NSCLC brain metastases","volume":"143","author":"Smith","year":"2019","journal-title":"J Neurooncol."},{"issue":"2","key":"2026061004511805500_CIT0097","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11060-024-04795-z","article-title":"Focused ultrasound-mediated enhancement of blood-brain barrier permeability for brain tumor treatment: a systematic review of clinical trials","volume":"170","author":"Zhu","year":"2024","journal-title":"J Neurooncol."},{"issue":"37","key":"2026061004511805500_CIT0098","doi-asserted-by":"crossref","first-page":"E8717","DOI":"10.1073\/pnas.1807105115","article-title":"Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption","volume":"115","author":"Arvanitis","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2026061004511805500_CIT0099","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1038\/s41467-024-52329-y","article-title":"Ultrasound frequency-controlled microbubble dynamics in brain vessels regulate the enrichment of inflammatory pathways in the blood-brain barrier","volume":"15","author":"Guo","year":"2024","journal-title":"Nat Commun."},{"key":"2026061004511805500_CIT0100","article-title":"Characterization of different microbubbles in assisting focused ultrasound-induced blood-brain barrier opening","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep."},{"issue":"12","key":"2026061004511805500_CIT0101","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1021\/acsbiomaterials.4c00777","article-title":"Effect of microbubble size, composition, and multiple sonication points on sterile inflammatory response in focused ultrasound-mediated blood-brain barrier opening","volume":"10","author":"Martinez","year":"2024","journal-title":"ACS Biomater Sci Eng."},{"key":"2026061004511805500_CIT0102","doi-asserted-by":"crossref","first-page":"114043","DOI":"10.1016\/j.addr.2021.114043","article-title":"Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound","volume":"180","author":"Schoen","year":"2022","journal-title":"Adv Drug Deliv Rev."},{"key":"2026061004511805500_CIT0103","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.actbio.2014.12.026","article-title":"Drug-loaded bubbles with matched focused ultrasound excitation for concurrent blood-brain barrier opening and brain-tumor drug delivery","volume":"15","author":"Fan","year":"2015","journal-title":"Acta Biomater."},{"issue":"2","key":"2026061004511805500_CIT0104","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s40846-015-0032-9","article-title":"Enhanced Therapeutic Epidermal Growth Factor Receptor (EGFR) antibody delivery via pulsed ultrasound with targeting microbubbles for glioma treatment","volume":"35","author":"Liao","year":"2015","journal-title":"J Med Biol Eng."},{"issue":"5","key":"2026061004511805500_CIT0105","first-page":"494","article-title":"Review of ultrasound mediated drug delivery for cancer treatment: updates from pre-clinical studies","volume":"3","author":"Couture","year":"2014","journal-title":"Transl Cancer Res."},{"issue":"1","key":"2026061004511805500_CIT0106","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3174\/ajnr.A3150","article-title":"Neuronavigation-guided focused ultrasound-induced blood-brain barrier opening: a preliminary study in swine","volume":"34","author":"Wei","year":"2013","journal-title":"AJNR Am J Neuroradiol."},{"issue":"14","key":"2026061004511805500_CIT0107","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1016\/j.biomaterials.2013.01.099","article-title":"SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery","volume":"34","author":"Fan","year":"2013","journal-title":"Biomaterials."},{"issue":"31","key":"2026061004511805500_CIT0108","doi-asserted-by":"crossref","first-page":"11719","DOI":"10.1073\/pnas.0604318103","article-title":"Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption","volume":"103","author":"Kinoshita","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"2026061004511805500_CIT0109","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.bbrc.2005.12.112","article-title":"Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound","volume":"340","author":"Kinoshita","year":"2006","journal-title":"Biochem Biophys Res Commun."},{"issue":"3","key":"2026061004511805500_CIT0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2012.09.007","article-title":"Ultrasound-mediated blood-brain\/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model","volume":"163","author":"Park","year":"2012","journal-title":"J Contr Release."},{"key":"2026061004511805500_CIT0111","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jconrel.2016.08.001","article-title":"Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption","volume":"238","author":"Kobus","year":"2016","journal-title":"J Control Release."},{"issue":"3","key":"2026061004511805500_CIT0112","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3171\/2018.9.JNS182001","article-title":"Blood-brain barrier disruption in humans using an implantable ultrasound device: quantification with MR images and correlation with local acoustic pressure","volume":"132","author":"Asquier","year":"2020","journal-title":"J Neurosurg."},{"key":"2026061004511805500_CIT0113","article-title":"Applications of focused ultrasound for primary brain tumors","author":"Ozair","year":"2025","journal-title":"Neurooncol. Adv.."},{"issue":"Supplement_5","key":"2026061004511805500_CIT0114","doi-asserted-by":"crossref","first-page":"v258","DOI":"10.1093\/neuonc\/noad179.0992","article-title":"RTID-01. A randomized study of low-intensity focused ultrasound for blood-brain barrier disruption for brain metastasis from non-small cell lung cancer (limitless)","volume":"25","author":"Ahluwalia","year":"2023","journal-title":"Neuro-Oncology."},{"issue":"3","key":"2026061004511805500_CIT0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.trecan.2018.01.003","article-title":"The evolving landscape of brain metastasis","volume":"4","author":"Valiente","year":"2018","journal-title":"Trends Cancer"},{"issue":"1","key":"2026061004511805500_CIT0116","doi-asserted-by":"crossref","first-page":"15713","DOI":"10.1038\/s41598-021-95287-x","article-title":"Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories","volume":"11","author":"Mizuno","year":"2021","journal-title":"Sci Rep."},{"issue":"5","key":"2026061004511805500_CIT0117","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaoncol.2016.5630","article-title":"Intrinsic Subtype Switching and Acquired ERBB2\/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases","volume":"3","author":"Priedigkeit","year":"2017","journal-title":"JAMA Oncol."},{"issue":"1","key":"2026061004511805500_CIT0118","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/s41467-020-18060-0","article-title":"Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases","volume":"11","author":"Rabbie","year":"2020","journal-title":"Nat Commun."},{"issue":"1","key":"2026061004511805500_CIT0119","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1038\/s41467-022-34899-x","article-title":"Decoding molecular programs in melanoma brain metastases","volume":"13","author":"Radke","year":"2022","journal-title":"Nat Commun."},{"issue":"4","key":"2026061004511805500_CIT0120","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell."},{"issue":"2","key":"2026061004511805500_CIT0121","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00262-016-1891-9","article-title":"Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies","volume":"66","author":"van den Bijgaart","year":"2017","journal-title":"Cancer Immunol Immunother."},{"issue":"2","key":"2026061004511805500_CIT0122","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11060-022-03973-1","article-title":"The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors","volume":"157","author":"Kim","year":"2022","journal-title":"J Neurooncol."},{"issue":"1","key":"2026061004511805500_CIT0123","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/pharmaceutics13010015","article-title":"Focused ultrasound and microbubbles-mediated drug delivery to brain tumor","volume":"13","author":"Wu","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"2026061004511805500_CIT0124","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7150\/thno.65597","article-title":"Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA","volume":"12","author":"Pacia","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"2026061004511805500_CIT0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10717544.2022.2157068","article-title":"Blood-cerebrospinal fluid barrier opening by modified single pulse transcranial focused shockwave","volume":"30","author":"Kung","year":"2023","journal-title":"Drug Deliv."},{"issue":"1","key":"2026061004511805500_CIT0126","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1038\/s41598-018-24516-7","article-title":"Focused ultrasound-enabled brain tumor liquid biopsy","volume":"8","author":"Zhu","year":"2018","journal-title":"Sci Rep."},{"issue":"1","key":"2026061004511805500_CIT0127","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1148\/radiol.2016160024","article-title":"Release of cell-free MicroRNA tumor biomarkers into the blood circulation with pulsed focused ultrasound: a noninvasive, anatomically localized, molecular liquid biopsy","volume":"283","author":"Chevillet","year":"2017","journal-title":"Radiology."},{"key":"2026061004511805500_CIT0128","article-title":"Noninvasive enrichment of circulating tumor biomarkers in a mouse model of diffuse midline glioma using focused ultrasound","author":"Chen","year":"2025","journal-title":"Neurooncol. Adv."},{"issue":"1","key":"2026061004511805500_CIT0129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11060-021-03861-0","article-title":"Current state of therapeutic focused ultrasound applications in neuro-oncology","volume":"156","author":"Meng","year":"2022","journal-title":"J Neurooncol."},{"issue":"10","key":"2026061004511805500_CIT0130","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/neuonc\/noab057","article-title":"MR-guided focused ultrasound liquid biopsy enriches circulating biomarkers in patients with brain tumors","volume":"23","author":"Meng","year":"2021","journal-title":"Neuro Oncol"},{"issue":"16_suppl","key":"2026061004511805500_CIT0131","doi-asserted-by":"crossref","first-page":"TPS2098","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS2098","article-title":"A prospective, multicenter trial of low-intensity focused ultrasound (LIFU) for blood-brain barrier disruption for liquid biopsy in glioblastoma (LIBERATE)","volume":"42","author":"Ahluwalia","year":"2024","journal-title":"J Clin Oncol."},{"issue":"Supplement_6","key":"2026061004511805500_CIT0132","doi-asserted-by":"crossref","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol"},{"issue":"suppl_6","key":"2026061004511805500_CIT0133","doi-asserted-by":"crossref","first-page":"vi1","DOI":"10.1093\/neuonc\/nov169","article-title":"CNS anticancer drug discovery and development conference white paper","volume":"17","author":"Levin","year":"2015","journal-title":"Neuro-Oncology."},{"issue":"224","key":"2026061004511805500_CIT0134","doi-asserted-by":"crossref","first-page":"224ra224","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med."},{"issue":"1","key":"2026061004511805500_CIT0135","doi-asserted-by":"crossref","first-page":"2237218","DOI":"10.1080\/02656736.2023.2237218","article-title":"Transcranial histotripsy parameter study in primary and metastatic murine brain tumor models","volume":"40","author":"Duclos","year":"2023","journal-title":"Int J Hyperthermia."},{"issue":"2","key":"2026061004511805500_CIT0136","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/nox175","article-title":"Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data","volume":"20","author":"Sarkaria","year":"2018","journal-title":"Neuro-Oncology."},{"issue":"4","key":"2026061004511805500_CIT0137","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1121\/10.0025832","article-title":"Ultrasound imaging guided precision histotripsy: effects of pulse settings on ablation properties in rat brain","volume":"155","author":"Landry","year":"2024","journal-title":"J Acoust Soc Am."},{"issue":"2","key":"2026061004511805500_CIT0138","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1158\/0008-5472.CAN-16-1711","article-title":"Quantitative fluorescence microscopy measures vascular pore size in primary and metastatic brain tumors","volume":"77","author":"Mittapalli","year":"2017","journal-title":"Cancer Res."},{"issue":"2","key":"2026061004511805500_CIT0139","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cncr.24735","article-title":"Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2\/neu-positive breast cancer","volume":"116","author":"Yonemori","year":"2010","journal-title":"Cancer."},{"issue":"2","key":"2026061004511805500_CIT0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3171\/2013.3.JNS122226","article-title":"Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms","volume":"119","author":"Nduom","year":"2013","journal-title":"J Neurosurg."},{"issue":"22","key":"2026061004511805500_CIT0141","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1158\/1078-0432.CCR-09-1349","article-title":"The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation","volume":"15","author":"Portnow","year":"2009","journal-title":"Clin Cancer Res."},{"issue":"1","key":"2026061004511805500_CIT0142","doi-asserted-by":"crossref","first-page":"e0166061","DOI":"10.1371\/journal.pone.0166061","article-title":"Effects on P-glycoprotein expression after blood-brain barrier disruption using focused ultrasound and microbubbles","volume":"12","author":"Aryal","year":"2017","journal-title":"PLoS One."},{"key":"2026061004511805500_CIT0143","doi-asserted-by":"crossref","first-page":"45657","DOI":"10.1038\/srep45657","article-title":"Acute effects of focused ultrasound-induced increases in blood-brain barrier permeability on rat microvascular transcriptome","volume":"7","author":"McMahon","year":"2017","journal-title":"Sci Rep."},{"key":"2026061004511805500_CIT0144","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fneur.2020.00544","article-title":"Next-Generation sequencing analysis of ctDNA for the detection of glioma and metastatic brain tumors in adults","volume":"11","author":"Liang","year":"2020","journal-title":"Front Neurol."},{"issue":"2","key":"2026061004511805500_CIT0145","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1016\/j.ijrobp.2024.07.786","article-title":"Enrichment of tumor-associated fragmentomic features in plasma with focused ultrasound-enabled liquid biopsy in glioma patients","volume":"120","author":"Chauhan","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"2026061004511805500_CIT0146","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.ultrasmedbio.2009.07.001","article-title":"Noninvasive thrombolysis using pulsed ultrasound cavitation therapy \u2013 histotripsy","volume":"35","author":"Maxwell","year":"2009","journal-title":"Ultrasound Med Biol."},{"issue":"2","key":"2026061004511805500_CIT0147","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/02656736.2015.1007538","article-title":"Histotripsy methods in mechanical disintegration of tissue: towards clinical applications","volume":"31","author":"Khokhlova","year":"2015","journal-title":"Int J Hyperthermia."},{"issue":"5","key":"2026061004511805500_CIT0148","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1109\/TUFFC.2016.2531504","article-title":"Targeted lesion generation through the skull without aberration correction using histotripsy","volume":"63","author":"Sukovich","year":"2016","journal-title":"IEEE Trans Ultrason Ferroelectr Freq Control."},{"issue":"1","key":"2026061004511805500_CIT0149","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/02656736.2021.1905189","article-title":"Histotripsy: the first noninvasive, non-ionizing, non-thermal ablation technique based on ultrasound","volume":"38","author":"Xu","year":"2021","journal-title":"Int J Hyperthermia."},{"issue":"5","key":"2026061004511805500_CIT0150","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ultrasmedbio.2018.10.035","article-title":"For whom the bubble grows: physical principles of bubble nucleation and dynamics in histotripsy ultrasound therapy","volume":"45","author":"Bader","year":"2019","journal-title":"Ultrasound Med Biol."},{"issue":"1","key":"2026061004511805500_CIT0151","doi-asserted-by":"crossref","first-page":"2233720","DOI":"10.1080\/02656736.2023.2233720","article-title":"The histotripsy spectrum: differences and similarities in techniques and instrumentation","volume":"40","author":"Williams","year":"2023","journal-title":"Int J Hyperthermia."},{"issue":"4","key":"2026061004511805500_CIT0152","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3171\/2018.4.JNS172652","article-title":"In vivo histotripsy brain treatment","volume":"131","author":"Sukovich","year":"2019","journal-title":"J Neurosurg."},{"issue":"14","key":"2026061004511805500_CIT0153","doi-asserted-by":"crossref","first-page":"e2300671","DOI":"10.1002\/adhm.202300671","article-title":"Development of a synthetic, injectable hydrogel to capture residual glioblastoma and glioblastoma stem-like cells with CXCL12-Mediated Chemotaxis","volume":"12","author":"Khan","year":"2023","journal-title":"Adv Healthc Mater"},{"issue":"8","key":"2026061004511805500_CIT0154","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ultrasmedbio.2024.04.001","article-title":"Neuronavigation-guided transcranial histotripsy (NaviTH) system","volume":"50","author":"Choi","year":"2024","journal-title":"Ultrasound Med Biol."},{"issue":"22","key":"2026061004511805500_CIT0155","doi-asserted-by":"crossref","first-page":"225006","DOI":"10.1088\/1361-6560\/ad8d9f","article-title":"Treatment envelope of transcranial histotripsy: challenges and strategies to maximize the treatment location profile","volume":"69","author":"Lu","year":"2024","journal-title":"Phys Med Biol."},{"issue":"10","key":"2026061004511805500_CIT0156","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1109\/TBME.2024.3399688","article-title":"Ultrasound-guided mechanical high-intensity focused ultrasound (Histotripsy) through an acoustically permeable polyolefin-based cranioplasty device","volume":"71","author":"Ruger","year":"2024","journal-title":"IEEE Trans Biomed Eng."},{"issue":"11","key":"2026061004511805500_CIT0157","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1109\/TUFFC.2018.2869689","article-title":"A low-cost miniature histotripsy transducer for precision tissue ablation","volume":"65","author":"Woodacre","year":"2018","journal-title":"IEEE Trans Ultrason Ferroelectr Freq Control."},{"issue":"9","key":"2026061004511805500_CIT0158","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1109\/TUFFC.2021.3078326","article-title":"A dual-frequency lens-focused endoscopic histotripsy transducer","volume":"68","author":"Mallay","year":"2021","journal-title":"IEEE Trans Ultrason Ferroelectr Freq Control."},{"key":"2026061004511805500_CIT0159","doi-asserted-by":"crossref","first-page":"9794321","DOI":"10.34133\/2022\/9794321","article-title":"Endoscopic coregistered ultrasound imaging and precision histotripsy: initial in vivo evaluation","volume":"2022","author":"Landry","year":"2022","journal-title":"BME Front."},{"key":"2026061004511805500_CIT0160","doi-asserted-by":"crossref","first-page":"107275","DOI":"10.1016\/j.ultras.2024.107275","article-title":"An 8\u00a0mm endoscopic histotripsy array with integrated high-resolution ultrasound imaging","volume":"139","author":"Mallay","year":"2024","journal-title":"Ultrasonics."},{"issue":"3","key":"2026061004511805500_CIT0161","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/2024.6.FOCUS24338","article-title":"A review of sonodynamic therapy for brain tumors","volume":"57","author":"Hutton","year":"2024","journal-title":"Neurosurg Focus."},{"issue":"4","key":"2026061004511805500_CIT0162","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.mric.2024.05.006","article-title":"MR Imaging-guided focused ultrasound-clinical applications in managing malignant gliomas","volume":"32","author":"Chen","year":"2024","journal-title":"Magn Reson Imaging Clin N Am."},{"issue":"4","key":"2026061004511805500_CIT0163","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3390\/cancers16040792","article-title":"The immunomodulatory effects of fluorescein-mediated sonodynamic treatment lead to systemic and intratumoral depletion of myeloid-derived suppressor cells in a preclinical Malignant Glioma model","volume":"16","author":"Pellegatta","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2026061004511805500_CIT0164","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1227\/NEU.0000000000001399","article-title":"Emerging applications of therapeutic ultrasound in neuro-oncology: moving beyond tumor ablation","volume":"79","author":"Hersh","year":"2016","journal-title":"Neurosurgery."},{"key":"2026061004511805500_CIT0165","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-3-319-22536-4_22","article-title":"Sonodynamic therapy: Concept, mechanism and application to cancer treatment","volume":"880","author":"McHale","year":"2016","journal-title":"Adv Exp Med Biol."},{"issue":"1","key":"2026061004511805500_CIT0166","doi-asserted-by":"crossref","first-page":"21791","DOI":"10.1038\/s41598-020-78153-0","article-title":"Sonodynamic therapy in combination with photodynamic therapy shows enhanced long-term cure of brain tumor","volume":"10","author":"Borah","year":"2020","journal-title":"Sci Rep."},{"key":"2026061004511805500_CIT0167","doi-asserted-by":"crossref","first-page":"109772","DOI":"10.1016\/j.clim.2023.109772","article-title":"Temozolomide-based sonodynamic therapy induces immunogenic cell death in glioma","volume":"256","author":"Zhou","year":"2023","journal-title":"Clin Immunol."},{"key":"2026061004511805500_CIT0168","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.wneu.2023.07.030","article-title":"Sonodynamic therapy and sonosensitizers for glioma treatment: a systematic qualitative review","volume":"178","author":"Mehta","year":"2023","journal-title":"World Neurosurg"},{"key":"2026061004511805500_CIT0169","first-page":"e65114","article-title":"Sonodynamic therapy for the treatment of glioblastoma multiforme in a mouse model using a portable benchtop focused ultrasound system","volume":"192","author":"Mess","year":"2023","journal-title":"J Vis Exp"},{"issue":"2","key":"2026061004511805500_CIT0170","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11060-021-03768-w","article-title":"Sonodynamic therapy for metastatic melanoma to the brain","volume":"153","author":"Sheehan","year":"2021","journal-title":"J Neurooncol."},{"issue":"1","key":"2026061004511805500_CIT0171","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11060-020-03504-w","article-title":"Investigation of the tumoricidal effects of sonodynamic therapy in malignant glioblastoma brain tumors","volume":"148","author":"Sheehan","year":"2020","journal-title":"J Neurooncol."},{"issue":"1","key":"2026061004511805500_CIT0172","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41467-019-09760-3","article-title":"Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice","volume":"10","author":"Yue","year":"2019","journal-title":"Nat Commun."},{"issue":"3","key":"2026061004511805500_CIT0173","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-020-03536-2","article-title":"Fluorescein-mediated sonodynamic therapy in a rat glioma model","volume":"148","author":"Prada","year":"2020","journal-title":"J Neurooncol."},{"issue":"1","key":"2026061004511805500_CIT0174","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.1038\/s41598-019-46832-2","article-title":"MR-guided focused ultrasound facilitates sonodynamic therapy with 5-Aminolevulinic acid in a Rat glioma model","volume":"9","author":"Wu","year":"2019","journal-title":"Sci Rep."},{"issue":"5","key":"2026061004511805500_CIT0175","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ultrasmedbio.2018.12.007","article-title":"Ultrasound hyperthermia technology for radiosensitization","volume":"45","author":"Zhu","year":"2019","journal-title":"Ultrasound Med Biol."},{"issue":"1","key":"2026061004511805500_CIT0176","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1038\/s41598-024-55442-6","article-title":"A study combining microbubble-mediated focused ultrasound and radiation therapy in the healthy rat brain and a F98 glioma model","volume":"14","author":"Fletcher","year":"2024","journal-title":"Sci Rep."},{"issue":"3","key":"2026061004511805500_CIT0177","first-page":"359","article-title":"Radiosensitization of allogenic subcutaneous C6 glioma model with focused ultrasound-induced Mild Hyperthermia","volume":"14","author":"Xu","year":"2024","journal-title":"Life (Basel)"},{"issue":"8","key":"2026061004511805500_CIT0178","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00066-021-01774-5","article-title":"Focused ultrasound radiosensitizes human cancer cells by enhancement of DNA damage","volume":"197","author":"Zhang","year":"2021","journal-title":"Strahlenther Onkol."},{"issue":"12","key":"2026061004511805500_CIT0179","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.3390\/cells9122595","article-title":"Focused ultrasound-induced cavitation sensitizes cancer cells to radiation therapy and hyperthermia","volume":"9","author":"Hu","year":"2020","journal-title":"Cells"},{"issue":"3","key":"2026061004511805500_CIT0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11060-023-04517-x","article-title":"Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study","volume":"165","author":"Chen","year":"2023","journal-title":"J Neurooncol."},{"issue":"1","key":"2026061004511805500_CIT0181","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1038\/s41598-023-40551-5","article-title":"Novel MRI-guided focussed ultrasound stimulated microbubble radiation enhancement treatment for breast cancer","volume":"13","author":"Dasgupta","year":"2023","journal-title":"Sci Rep."},{"key":"2026061004511805500_CIT0182","doi-asserted-by":"crossref","first-page":"102115","DOI":"10.1016\/j.tranon.2024.102115","article-title":"Tumor perfusion enhancement by focus ultrasound-induced blood-brain barrier opening to potentiate anti-PD-1 immunotherapy of glioma","volume":"49","author":"Shan","year":"2024","journal-title":"Transl Oncol."},{"issue":"2","key":"2026061004511805500_CIT0183","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/pharmaceutics15020455","article-title":"Low-intensity pulsed ultrasound-mediated blood-brain barrier opening increases anti-programmed death-ligand 1 delivery and efficacy in Gl261 mouse model","volume":"15","author":"Ahmed","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"2026061004511805500_CIT0184","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-021-03887-4","article-title":"Profiling of the immune landscape in murine glioblastoma following blood brain\/tumor barrier disruption with MR image-guided focused ultrasound","volume":"156","author":"Sheybani","year":"2022","journal-title":"J Neurooncol."},{"issue":"9","key":"2026061004511805500_CIT0185","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.4049\/jimmunol.1901430","article-title":"Focused ultrasound for immunomodulation of the tumor microenvironment","volume":"205","author":"Joiner","year":"2020","journal-title":"J Immunol."},{"issue":"1","key":"2026061004511805500_CIT0186","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1073\/pnas.1614777114","article-title":"Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation","volume":"114","author":"Kovacs","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"2026061004511805500_CIT0187","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1158\/0008-5472.CAN-12-2609","article-title":"Focused ultrasound delivers targeted immune cells to metastatic brain tumors","volume":"73","author":"Alkins","year":"2013","journal-title":"Cancer Res."},{"key":"2026061004511805500_CIT0188","article-title":"FUS, immunomodulation, and immunotherapies","author":"Sheybani","year":"2025","journal-title":"Neuro-Oncol Adv"},{"issue":"15","key":"2026061004511805500_CIT0189","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.7150\/thno.21225","article-title":"Focused ultrasound immunotherapy for central nervous system pathologies: challenges and opportunities","volume":"7","author":"Curley","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"2026061004511805500_CIT0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12967-015-0451-y","article-title":"Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study","volume":"13","author":"Chen","year":"2015","journal-title":"J Transl Med."},{"issue":"15","key":"2026061004511805500_CIT0191","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-20-3760","article-title":"Opening of the blood\u2013brain barrier using low-intensity pulsed ultrasound enhances responses to immunotherapy in preclinical glioma models","volume":"27","author":"Sabbagh","year":"2021","journal-title":"Clin Cancer Res."},{"issue":"11","key":"2026061004511805500_CIT0192","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41551-021-00779-w","article-title":"Control of the activity of CAR-T cells within tumours via focused ultrasound","volume":"5","author":"Wu","year":"2021","journal-title":"Nat Biomed Eng."},{"issue":"16","key":"2026061004511805500_CIT0193","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.7150\/thno.46534","article-title":"Focused ultrasound hyperthermia augments release of glioma-derived extracellular vesicles with differential immunomodulatory capacity","volume":"10","author":"Sheybani","year":"2020","journal-title":"Theranostics"},{"issue":"8","key":"2026061004511805500_CIT0194","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41591-023-02466-6","article-title":"Precise, pragmatic and inclusive: the modern era of oncology clinical trials","volume":"29","author":"Grant","year":"2023","journal-title":"Nat Med."},{"issue":"4","key":"2026061004511805500_CIT0195","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41591-022-01775-6","article-title":"Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition","volume":"28","author":"Li","year":"2022","journal-title":"Nat Med."},{"issue":"4","key":"2026061004511805500_CIT0196","doi-asserted-by":"crossref","first-page":"e246228","DOI":"10.1001\/jamanetworkopen.2024.6228","article-title":"Remote monitoring and data collection for decentralized clinical trials","volume":"7","author":"Daly","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026061004511805500_CIT0197","volume-title":"Cancer Clinical Trial Eligibility Criteria: Available Therapy in Non-Curative Settings","author":"FDA","year":"2022"},{"issue":"3","key":"2026061004511805500_CIT0198","doi-asserted-by":"crossref","first-page":"e068057","DOI":"10.1136\/bmjopen-2022-068057","article-title":"Registry randomised trials: a methodological perspective","volume":"13","author":"Doherty","year":"2023","journal-title":"BMJ Open"},{"issue":"10","key":"2026061004511805500_CIT0199","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1016\/S1470-2045(21)00488-5","article-title":"Leveraging external data in the design and analysis of clinical trials in neuro-oncology","volume":"22","author":"Rahman","year":"2021","journal-title":"Lancet Oncol."},{"issue":"2","key":"2026061004511805500_CIT0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1515\/ijb-2022-0056","article-title":"Causal inference for oncology: past developments and current challenges","volume":"19","author":"Moodie","year":"2023","journal-title":"Int J Biostat"},{"issue":"9","key":"2026061004511805500_CIT0201","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jclinepi.2015.05.029","article-title":"Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations","volume":"68","author":"Patel","year":"2015","journal-title":"J Clin Epidemiol."},{"key":"2026061004511805500_CIT0202","volume-title":"The garden of forking paths: Why multiple comparisons can be a problem, even when there is no shing expedition or p-hacking and the research hypothesis was posited ahead of time","author":"Gelman"},{"key":"2026061004511805500_CIT0203","doi-asserted-by":"crossref","first-page":"e82268","DOI":"10.7554\/eLife.82268","article-title":"Misstatements, misperceptions, and mistakes in controlling for covariates in observational research","volume":"13","author":"Yu","year":"2024","journal-title":"Elife"},{"issue":"1","key":"2026061004511805500_CIT0204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/embor.2008.237","article-title":"The good, the bad and the ugly red tape of biomedical research. How could regulators lower bureaucratic hurdles in clinical research without compromising the safety of patients","volume":"10","author":"Greener","year":"2009","journal-title":"EMBO Rep."},{"issue":"2","key":"2026061004511805500_CIT0205","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3171\/2014.12.JNS142465","article-title":"Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered","volume":"124","author":"Mansouri","year":"2016","journal-title":"J Neurosurg."},{"issue":"17","key":"2026061004511805500_CIT0206","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1001\/jama.2012.3424","article-title":"Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010","volume":"307","author":"Califf","year":"2012","journal-title":"JAMA."},{"issue":"1","key":"2026061004511805500_CIT0207","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.annonc.2022.09.158","article-title":"Oncology phase I trial design and conduct: time for a change \u2013 MDICT Guidelines 2022","volume":"34","author":"Araujo","year":"2023","journal-title":"Ann Oncol."},{"issue":"1","key":"2026061004511805500_CIT0208","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2007.07.031","article-title":"Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT)","volume":"44","author":"Booth","year":"2008","journal-title":"Eur J Cancer."},{"issue":"11","key":"2026061004511805500_CIT0209","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1158\/1078-0432.CCR-19-3136","article-title":"Design and conduct of early clinical studies of immunotherapy: recommendations from the task force on methodology for the development of innovative cancer therapies 2019 (MDICT)","volume":"26","author":"Smoragiewicz","year":"2020","journal-title":"Clin Cancer Res."},{"issue":"36","key":"2026061004511805500_CIT0210","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1200\/JCO.23.00493","article-title":"Inaugural results of the individualized screening trial of innovative glioblastoma therapy: a phase II platform trial for newly diagnosed glioblastoma using bayesian adaptive randomization","volume":"41","author":"Rahman","year":"2023","journal-title":"J Clin Oncol."},{"issue":"4","key":"2026061004511805500_CIT0211","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/19466315.2016.1207561","article-title":"Using outcomes to analyze patients rather than patients to analyze outcomes: a step toward pragmatism in benefit:risk evaluation","volume":"8","author":"Evans","year":"2016","journal-title":"Stat Biopharm Res"},{"issue":"3","key":"2026061004511805500_CIT0212","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41573-023-00638-0","article-title":"Application of Bayesian approaches in drug development: starting a virtuous cycle","volume":"22","author":"Ruberg","year":"2023","journal-title":"Nat Rev Drug Discov."},{"key":"2026061004511805500_CIT0213","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1200\/EDBK_100028","article-title":"An arm and a leg: the rising cost of cancer drugs and impact on access","volume":"41","author":"Leighl","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book."},{"issue":"2","key":"2026061004511805500_CIT0214","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3171\/2015.12.JNS152894","article-title":"Letter to the editor: methodological advances in randomized trials","volume":"125","author":"Kolias","year":"2016","journal-title":"J Neurosurg."},{"issue":"3","key":"2026061004511805500_CIT0215","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1740774512438980","article-title":"National institute of neurological disorders and stroke common data element project - approach and methods","volume":"9","author":"Grinnon","year":"2012","journal-title":"Clin Trials."},{"issue":"1","key":"2026061004511805500_CIT0216","doi-asserted-by":"crossref","first-page":"e000284","DOI":"10.1136\/bmjmed-2022-000284","article-title":"Core outcome sets in medical research","volume":"1","author":"Kirkham","year":"2022","journal-title":"BMJ Med."},{"issue":"Suppl 3","key":"2026061004511805500_CIT0217","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET handbook: version 1.0","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"issue":"11","key":"2026061004511805500_CIT0218","doi-asserted-by":"crossref","first-page":"e1002447","DOI":"10.1371\/journal.pmed.1002447","article-title":"Core outcome set-STAndards for development: the COS-STAD recommendations","volume":"14","author":"Kirkham","year":"2017","journal-title":"PLoS Med."},{"key":"2026061004511805500_CIT0219","doi-asserted-by":"crossref","first-page":"563840","DOI":"10.3389\/fonc.2020.563840","article-title":"Blood-brain barrier disruption in neuro-oncology: strategies, failures, and challenges to overcome","volume":"10","author":"Karmur","year":"2020","journal-title":"Front Oncol."},{"issue":"7","key":"2026061004511805500_CIT0220","doi-asserted-by":"crossref","first-page":"e2011985","DOI":"10.1001\/jamanetworkopen.2020.11985","article-title":"Evaluation of the use of cancer registry data for comparative effectiveness research","volume":"3","author":"Kumar","year":"2020","journal-title":"JAMA Netw Open."},{"issue":"4","key":"2026061004511805500_CIT0221","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/neuonc\/noad242","article-title":"Defining interventions and metrics to improve diversity in CNS clinical trial participation: a SNO and RANO effort","volume":"26","author":"Budhu","year":"2024","journal-title":"Neuro-Oncology."},{"key":"2026061004511805500_CIT0222","article-title":"Current state and future of clinical focused ultrasound devices","author":"Kassell","year":"2025","journal-title":"Neurooncol Adv"},{"issue":"5","key":"2026061004511805500_CIT0223","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1227\/neu.0000000000002542","article-title":"Causes of death in patients with brain metastases","volume":"93","author":"Schnurman","year":"2023","journal-title":"Neurosurgery."},{"issue":"11","key":"2026061004511805500_CIT0224","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1016\/S1470-2045(24)00315-2","article-title":"Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice","volume":"25","author":"Bakas","year":"2024","journal-title":"Lancet Oncol."},{"issue":"1","key":"2026061004511805500_CIT0225","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: issues to consider","volume":"13","author":"Williamson","year":"2012","journal-title":"Trials"},{"key":"2026061004511805500_CIT0226","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jclinepi.2022.06.016","article-title":"Review finds core outcome set uptake in new studies and systematic reviews needs improvement","volume":"150","author":"Williamson","year":"2022","journal-title":"J Clin Epidemiol."},{"issue":"1","key":"2026061004511805500_CIT0227","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3174\/ajnr.A8405","article-title":"State of practice on transcranial MR-guided focused ultrasound: a report from the ASNR standards and guidelines committee and ACR Commission on Neuroradiology Workgroup","volume":"46","author":"Shah","year":"2024","journal-title":"AJNR Am J Neuroradiol."},{"issue":"4","key":"2026061004511805500_CIT0228","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1215\/15228517-2008-021","article-title":"Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium","volume":"10","author":"Chang","year":"2008","journal-title":"Neuro Oncol"},{"issue":"3","key":"2026061004511805500_CIT0229","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/14737140.2022.2038138","article-title":"High-grade glioma therapy: adding flexibility in trial design to improve patient outcomes","volume":"22","author":"Ye","year":"2022","journal-title":"Expert Rev Anticancer Ther."},{"issue":"4","key":"2026061004511805500_CIT0230","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/1078-0432.CCR-17-0764","article-title":"Adaptive global innovative learning environment for glioblastoma: GBM AGILE","volume":"24","author":"Alexander","year":"2018","journal-title":"Clin Cancer Res."},{"key":"2026061004511805500_CIT0231","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.wneu.2021.07.061","article-title":"Adaptive designs: benefits and cautions for neurosurgery trials","volume":"161","author":"Mukherjee","year":"2022","journal-title":"World Neurosurg."},{"issue":"8","key":"2026061004511805500_CIT0232","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1158\/1078-0432.CCR-22-3334","article-title":"National cancer institute combination therapy platform trial with molecular analysis for therapy choice (ComboMATCH)","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin Cancer Res."},{"issue":"2","key":"2026061004511805500_CIT0233","first-page":"81","article-title":"Opportunities and challenges of incorporating clinical outcome assessments in brain tumor clinical trials","volume":"6","author":"Molinari","year":"2019","journal-title":"Neurooncol. Pract."},{"issue":"21","key":"2026061004511805500_CIT0234","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1200\/JCO.2017.72.7511","article-title":"Response assessment in neuro-oncology clinical trials","volume":"35","author":"Wen","year":"2017","journal-title":"J Clin Oncol."},{"issue":"1","key":"2026061004511805500_CIT0235","first-page":"4","article-title":"Clinical outcome assessments in neuro-oncology: a regulatory perspective","volume":"3","author":"Sul","year":"2016","journal-title":"Neurooncol. Pract.."},{"issue":"5","key":"2026061004511805500_CIT0236","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/neuonc\/nov024","article-title":"Getting it first versus getting it right: weighing the value of and evidence for progression-free survival as a surrogate endpoint for overall survival in glioblastoma","volume":"17","author":"Alexander","year":"2015","journal-title":"Neuro Oncol"},{"key":"2026061004511805500_CIT0237"},{"issue":"10","key":"2026061004511805500_CIT0238","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1016\/S1470-2045(13)70308-5","article-title":"Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group","volume":"14","author":"Lin","year":"2013","journal-title":"Lancet Oncol."},{"issue":"1","key":"2026061004511805500_CIT0239","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41416-019-0621-4","article-title":"Window of opportunity clinical trial designs to study cancer metabolism","volume":"122","author":"Aroldi","year":"2020","journal-title":"Br J Cancer."}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdaf131\/67415819\/vdaf131.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/Supplement_4\/iv40\/67415819\/vdaf131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/Supplement_4\/iv40\/67415819\/vdaf131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:52:01Z","timestamp":1781081521000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/8\/Supplement_4\/iv40\/8529038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":239,"journal-issue":{"issue":"Supplement_4","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdaf131","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2025,12,2]]}}}